Jupiter Wellness, Inc.: Jupiter Wellness' Merger Partner Next Frontier Pharmaceuticals, Inc. Enters Psychedelic Drug Development and API Market

Next Frontier Pharmaceuticals' Subsidiary Benuvia Signs Agreement with Global Wellness' Shanti TherapeuticsBenuvia has begun focusing on Psilocybin, DMT, and MDMA.Benuvia's 83,000 square foot synthetic

Related Keywords

Round Rock ,Texas ,United States ,Brandon Kidd ,Kostenloser Wertpapierhandel ,Jupiter Wellnes ,Erik Fordyce ,Shannon Soqui ,Frontier Pharmaceuticals Inc ,Shanti Therapeutics Pty Ltd ,Jupiter Wellness Inc ,Frontier Pharmaceuticals ,Nasdaq ,Exchange Commission ,Benuvia Manufacturing Inc ,Frontier Pharmaceuticals Investor Contact ,Business Development ,Global Wellness Strategies Inc ,Global Wellnes Shanti ,Jupiter Wellness ,Next Frontier Pharmaceuticals ,Benuvia Manufacturing ,Active Pharmaceutical Ingredient ,Executive Chairman ,Next Frontier ,Next Frontier Pharmaceutical ,Shanti Therapeutics ,Chief Business Development Officer ,Meris Kott ,Global Wellness Strategies ,Investigational New Drugs ,Therapeutics Pty Ltd ,Wellness Investor Contact ,Jupiter Wellnes Securities ,Jupiter Wellnes Annual Report ,Quarterly Report ,Jupiter ,Wellness ,Berger ,Partner ,Text ,Frontier ,Pharmaceuticals ,Centers ,Sychedelic ,Drug ,Development ,Market ,